Literature DB >> 11562070

Severe impairment of anti-cancer effect of lipoteichoic acid-related molecule isolated from a penicillin-killed Streptococcus pyogenes in toll-like receptor 4-deficient mice.

M Okamoto1, T Oshikawa, G Ohe, H Nishikawa, S Furuichi, T Tano, Y Moriya, M Saito, M Sato.   

Abstract

A lipoteichoic acid-related molecule (OK-PSA) isolated from OK-432, a penicillin-killed Streptococcus pyogenes, is a potent inducer of Th1 cytokines, and elicits anti-cancer effect in tumor-bearing mice. Toll-like receptor (TLR) 4 is a member of the recently identified toll-like receptor family of proteins that has been implicated in lipopolysaccharide-induced cell signaling. In the present study, we have examined the role of TLR4 for OK-PSA-induced Th1-cytokine production and anti-tumor effect by using C3H/HeJ mice in which TLR4 function is impaired. Although OK-PSA strikingly induced Th1 cytokines [interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, interleukin (IL)-2, IL-12 and IL-18] in the splenocytes derived from control animals (C3H/HeN), OK-PSA did not induce the cytokines in the splenocytes from C3H/HeJ. Furthermore, C3H/HeJ-derived splenocytes acquired the responsiveness to OK-PSA stimulation by overexpression of TLR4 gene. Finally, OK-PSA administration significantly inhibited the tumor growth and lung metastasis of syngeneic squamous cell carcinoma cells in C3H/HeN; however, no effect of OK-PSA was observed in C3H/HeJ. These findings strongly suggest that TLR4 signaling is involved in regulating OK-PSA-induced anti-cancer immunity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562070     DOI: 10.1016/s1567-5769(01)00103-5

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

1.  Interleukin-13 protects mouse intestine from ischemia and reperfusion injury through regulation of innate and adaptive immunity.

Authors:  Douglas G Farmer; Bibo Ke; Xiu-Da Shen; Fady M Kaldas; Feng Gao; Melissa J Watson; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Transplantation       Date:  2011-04-15       Impact factor: 4.939

2.  Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.

Authors:  Huan Yang; Huiqin Zhou; Ping Feng; Xiaoni Zhou; Huiyan Wen; Xiaofang Xie; Haiying Shen; Xueming Zhu
Journal:  J Exp Clin Cancer Res       Date:  2010-07-10

3.  Inhibition of dendritic cell maturation by group A Streptococcus.

Authors:  Guadalupe Cortés; Michael R Wessels
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226

4.  Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant.

Authors:  Masato Okamoto; Go Oh-E; Tetsuya Oshikawa; Sachiko Furuichi; Tomoyuki Tano; Sharif U Ahmed; Sachiko Akashi; Kensuke Miyake; Osamu Takeuchi; Shizuo Akira; Kunisuke Himeno; Mitsunobu Sato; Shinya Ohkubo
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

5.  Immunochemoradiotherapy for patients with oral squamous cell carcinoma: augmentation of OK-432-induced helper T cell 1 response by 5-FU and X-ray irradiation.

Authors:  Tomoyuki Tano; Masato Okamoto; Shin Kan; Takashi Bando; Hiroyuki Goda; Koh-ichi Nakashiro; Shigetaka Shimodaira; Shigeo Koido; Sadamu Homma; Tomonobu Fujita; Mitsunobu Sato; Naomi Yamashita; Hiroyuki Hamakawa; Yutaka Kawakami
Journal:  Neoplasia       Date:  2013-07       Impact factor: 5.715

6.  Expression and Polymorphism of Toll-Like Receptor 4 and Effect on NF-κB Mediated Inflammation in Colon Cancer Patients.

Authors:  Abdelhabib Semlali; Narasimha Reddy Parine; Maha Arafah; Lamjed Mansour; Arezki Azzi; Omair Al Shahrani; Abdullah Al Amri; Jilani P Shaik; Abdulrahman M Aljebreen; Othman Alharbi; Majid A Almadi; Nahla Ali Azzam; Muhammad Kohailan; Mahmoud Rouabhia; Mohammad Saud Alanazi
Journal:  PLoS One       Date:  2016-01-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.